Brown JT - Search Results

1

Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.

Brown JT, Bishop JR, Sangkuhl K, Nurmi EL, Mueller DJ, Dinh JC, Gaedigk A, Klein TE, Caudle KE, McCracken JT, de Leon J, Leeder JS. Brown JT, et al. Clin Pharmacol Ther. 2019 Jul;106(1):94-102. doi: 10.1002/cpt.1409. Epub 2019 Apr 13. Clin Pharmacol Ther. 2019. PMID: 30801677 Free PMC article.

2

Atomoxetine pharmacogenetics: associations with pharmacokinetics, treatment response and tolerability.

Brown JT, Bishop JR. Brown JT, et al. Pharmacogenomics. 2015;16(13):1513-20. doi: 10.2217/PGS.15.93. Epub 2015 Aug 28. Pharmacogenomics. 2015. PMID: 26314574 Review.

3

Pharmacogenomics of autism spectrum disorder.

Brown JT, Eum S, Cook EH, Bishop JR. Brown JT, et al. Pharmacogenomics. 2017 Mar;18(4):403-414. doi: 10.2217/pgs-2016-0167. Epub 2017 Feb 22. Pharmacogenomics. 2017. PMID: 28244813 Review.

4

Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.

Brown JT, Schneiderhan M, Eum S, Bishop JR. Brown JT, et al. Pharmacogenomics. 2017 May;18(7):601-605. doi: 10.2217/pgs-2017-0015. Epub 2017 May 4. Pharmacogenomics. 2017. PMID: 28470111 Review.

5

Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report.

Eum S, Schneiderhan ME, Brown JT, Lee AM, Bishop JR. Eum S, et al. Among authors: brown jt. BMC Psychiatry. 2017 Jul 3;17(1):238. doi: 10.1186/s12888-017-1396-x. BMC Psychiatry. 2017. PMID: 28673279 Free PMC article.

6

PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.

Stevens T, Sangkuhl K, Brown JT, Altman RB, Klein TE. Stevens T, et al. Among authors: brown jt. Pharmacogenet Genomics. 2019 Aug;29(6):136-154. doi: 10.1097/FPC.0000000000000376. Pharmacogenet Genomics. 2019. PMID: 30950912 Free PMC article. Review. No abstract available.

7

Gene-Based Dose Optimization in Children.

Ramsey LB, Brown JT, Vear SI, Bishop JR, Van Driest SL. Ramsey LB, et al. Among authors: brown jt. Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:311-331. doi: 10.1146/annurev-pharmtox-010919-023459. Epub 2019 Jul 5. Annu Rev Pharmacol Toxicol. 2020. PMID: 31283429 Free PMC article. Review.

8

Using pharmacogenomics and therapeutic drug monitoring to guide drug selection and dosing in outpatient mental health comprehensive medication management.

Brown JT, Bishop JR, Schneiderhan ME. Brown JT, et al. Ment Health Clin. 2020 Jul 2;10(4):254-258. doi: 10.9740/mhc.2020.07.254. eCollection 2020 Jul. Ment Health Clin. 2020. PMID: 32685338 Free PMC article.

9

Strategies and settings of clinical pharmacogenetic implementation: a scoping review of pharmacogenetics programs.

Luczak T, Brown SJ, Armbruster D, Hundertmark M, Brown J, Stenehjem D. Luczak T, et al. Pharmacogenomics. 2021 Apr;22(6):345-364. doi: 10.2217/pgs-2020-0181. Epub 2021 Apr 8. Pharmacogenomics. 2021. PMID: 33829852 Review.

10

Current strategies for predicting side effects from second generation antipsychotics in youth.

Brown JT, Campo-Soria C, Bishop JR. Brown JT, et al. Expert Opin Drug Metab Toxicol. 2021 Jun;17(6):655-664. doi: 10.1080/17425255.2021.1922668. Epub 2021 May 2. Expert Opin Drug Metab Toxicol. 2021. PMID: 33896324 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters